Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance

Lead

University Hospitals Cleveland Medical Center

With

• National Alliance for Research on Schizophrenia and Depression
• Takeda Pharmaceuticals North America, Inc.